Market Closed -
Bombay S.E.
06:00:51 2024-05-10 EDT
|
5-day change
|
1st Jan Change
|
181.5
INR
|
-1.20%
|
|
-1.31%
|
+11.56%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
716.3
|
475
|
200.8
|
494.4
|
684.4
|
731.4
|
Enterprise Value (EV)
1 |
691.5
|
440.5
|
180.9
|
424
|
493.9
|
425.5
|
P/E ratio
|
1
x
|
2.67
x
|
4.14
x
|
-22
x
|
2.09
x
|
3.53
x
|
Yield
|
1.84%
|
2.77%
|
6.56%
|
2.66%
|
2.41%
|
2.25%
|
Capitalization / Revenue
|
11.5
x
|
1.46
x
|
1.55
x
|
2.16
x
|
3.27
x
|
3.97
x
|
EV / Revenue
|
11.1
x
|
1.35
x
|
1.39
x
|
1.86
x
|
2.36
x
|
2.31
x
|
EV / EBITDA
|
-25.6
x
|
-24.5
x
|
-14.4
x
|
145
x
|
-250
x
|
-12.1
x
|
EV / FCF
|
-5.45
x
|
-21
x
|
-6.39
x
|
-12.4
x
|
2.87
x
|
-5.95
x
|
FCF Yield
|
-18.4%
|
-4.76%
|
-15.6%
|
-8.04%
|
34.8%
|
-16.8%
|
Price to Book
|
0.49
x
|
0.29
x
|
0.12
x
|
0.3
x
|
0.35
x
|
0.34
x
|
Nbr of stocks (in thousands)
|
6,583
|
6,583
|
6,583
|
6,583
|
6,583
|
6,583
|
Reference price
2 |
108.8
|
72.15
|
30.50
|
75.10
|
104.0
|
111.1
|
Announcement Date
|
18-05-29
|
19-08-01
|
20-09-04
|
21-07-12
|
22-09-02
|
23-08-11
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
62.3
|
325.8
|
129.8
|
228.4
|
209
|
184.1
|
EBITDA
1 |
-27.03
|
-17.98
|
-12.54
|
2.934
|
-1.979
|
-35.21
|
EBIT
1 |
-34.86
|
-24.78
|
-18.89
|
-3.081
|
-7.923
|
-39.48
|
Operating Margin
|
-55.95%
|
-7.61%
|
-14.55%
|
-1.35%
|
-3.79%
|
-21.44%
|
Earnings before Tax (EBT)
1 |
886.2
|
185
|
53.91
|
239.1
|
425.9
|
269
|
Net income
1 |
716.5
|
177.6
|
48.56
|
-22.44
|
326.9
|
207.2
|
Net margin
|
1,150.05%
|
54.52%
|
37.42%
|
-9.82%
|
156.42%
|
112.53%
|
EPS
2 |
108.8
|
26.98
|
7.376
|
-3.408
|
49.66
|
31.48
|
Free Cash Flow
1 |
-127
|
-20.98
|
-28.31
|
-34.1
|
171.9
|
-71.48
|
FCF margin
|
-203.84%
|
-6.44%
|
-21.82%
|
-14.93%
|
82.26%
|
-38.82%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
52.59%
|
-
|
Dividend per Share
2 |
2.000
|
2.000
|
2.000
|
2.000
|
2.500
|
2.500
|
Announcement Date
|
18-05-29
|
19-08-01
|
20-09-04
|
21-07-12
|
22-09-02
|
23-08-11
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
24.8
|
34.5
|
19.9
|
70.4
|
190
|
306
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-127
|
-21
|
-28.3
|
-34.1
|
172
|
-71.5
|
ROE (net income / shareholders' equity)
|
64.1%
|
11.4%
|
2.94%
|
-1.36%
|
18.3%
|
10.2%
|
ROA (Net income/ Total Assets)
|
-1.78%
|
-0.96%
|
-0.69%
|
-0.1%
|
-0.23%
|
-1%
|
Assets
1 |
-40,311
|
-18,444
|
-7,040
|
21,388
|
-141,401
|
-20,678
|
Book Value Per Share
2 |
224.0
|
248.0
|
253.0
|
248.0
|
296.0
|
325.0
|
Cash Flow per Share
2 |
1.160
|
5.230
|
3.010
|
2.190
|
0.8600
|
10.60
|
Capex
1 |
3.69
|
-
|
-
|
0.07
|
12.9
|
3.04
|
Capex / Sales
|
5.92%
|
-
|
-
|
0.03%
|
6.16%
|
1.65%
|
Announcement Date
|
18-05-29
|
19-08-01
|
20-09-04
|
21-07-12
|
22-09-02
|
23-08-11
|
|
1st Jan change
|
Capi.
|
---|
| +11.56% | 14.3M | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|